• We examined whether (1) there is an association between elevated circulating levels of transforming growth factor–β (TGF-β) and splenocyte dysfunction during sepsis, and (2) administration of monoclonal antibodies to interleukin 6 (an inducer of TGF-β release) or TGF-β could ablate these changes. Blood and splenocytes were obtained from C3H/HeN mice at 1, 4, or 24 hours following cecal ligation and puncture or sham operation. Only at 24 hours after cecal ligation and puncture was there an association between elevated blood TGF-β value and depressed splenocyte interleukin 2 release. Administration of monoclonal antibodies against interleukin 6, but not against TGF-β (intraperitoneally immediately following cecal ligation and puncture), significantly decreased the blood levels of TGF-β at 24 hours following cecal ligation and puncture and improved splenocyte interleukin 2 release. Thus, the judicious use of monoclonal antibodies against interleukin 6 may block the subsequent elevation of TGF-β, thereby attenuating host immunosuppression during sepsis.
(Arch Surg. 1993;128:89-95)
Ayala A, Knotts JB, Ertel W, Perrin MM, Morrison MH, Chaudry IH. Role of Interleukin 6 and Transforming Growth Factor–β in the Induction of Depressed Splenocyte Responses Following Sepsis. Arch Surg. 1993;128(1):89–95. doi:10.1001/archsurg.1993.01420130101015
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: